Cara Therapeutics Inc (LTS:0HTC)
$ 0.2819 0.0076 (2.77%) Market Cap: 14.95 Mil Enterprise Value: -23.67 Mil PE Ratio: 0 PB Ratio: 22.46 GF Score: 31/100

Cara Therapeutics, Inc. - Special Call Transcript

Apr 21, 2020 / 12:30PM GMT
Release Date Price: $11.94
Operator

Good morning, and welcome to Cara Therapeutics KALM-2 top line data conference call. (Operator Instructions) Please be advised, the call is being recorded at Cara's request.

I would now like to turn the call over to the Cara team. Please proceed.

Jane Urheim
Stern Investor Relations, Inc. - IR Executive

Good morning. This is Jane Urheim with Stern Investor Relations, and welcome to Cara Therapeutics KALM-2 top line data conference call. The news release became available earlier this morning and can be found on our website at www.caratherapeutics.com. You may also listen to a live webcast and replay of today's call on the News and Investors section of the website.

Before we begin, let me remind you that statements made on today's call regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements include statements concerning plans,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot